KSE Scientific
Acquisition in 2021
KSE Scientific is a bioprocess manufacturer focused on producing sterile products for the tissue banking, pharmaceutical, and biotech sectors. The company specializes in sterile bioprocessing production and provides comprehensive services that include initial packaging sourcing, validation and testing, as well as long-term production of critical sterile products. Additionally, KSE Scientific offers Good Manufacturing Practice (GMP) warehousing and distribution services, ensuring that clients receive high-quality products tailored to their specific needs in the life sciences industry.
Flexan
Acquisition in 2021
Flexan Corporation is a specialized manufacturer of custom molded rubber and rubber parts, with a strong focus on the medical device industry. Founded in 1946 and headquartered in Chicago, Illinois, the company provides a comprehensive range of engineering services, including project design assistance, tooling design, prototyping, and material recommendations. Flexan's expertise encompasses silicone, thermoplastic, and specialty rubber, enabling it to meet the stringent requirements of class I, II, and III medical devices. The company serves a diverse clientele across various sectors, including healthcare, automotive, military, and industrial controls, ensuring that products adhere to high quality and regulatory standards. With over seventy years of experience, Flexan is committed to delivering precision and innovation in its manufacturing processes, supporting clients in the development of compliant and high-performance products.
Solo Containment
Acquisition in 2020
Solo Containment Limited, founded in 2011 and based in Greater Manchester, England, specializes in the manufacturing of flexible film isolators tailored for the pharmaceutical and biopharma sectors. The company offers a diverse range of products, including lab-scale solutions for low potency processing, a versatile line for pharmaceutical applications, custom aseptic processing isolators, and single-use containment options that address specific engineering challenges. By focusing on niche high-potency active pharmaceutical ingredient (HPAPI) applications, Solo Containment serves a global clientele, providing innovative containment solutions designed to meet the evolving needs of the industry. As of September 2020, the company operates as a subsidiary of ILC Dover, Incorporated.